These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 17552415

  • 1. [Guideline 'Cardiovascular Risk Management'].
    Burgers JS, Simoons ML, Hoes AW, Stehouwer CD, Stalman WA.
    Ned Tijdschr Geneeskd; 2007 May 12; 151(19):1068-74. PubMed ID: 17552415
    [Abstract] [Full Text] [Related]

  • 2. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Sinclair G, Kerr A.
    N Z Med J; 2006 Nov 17; 119(1245):U2312. PubMed ID: 17146487
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preventing cardiovascular disease in women.
    Hayes SN.
    Am Fam Physician; 2006 Oct 15; 74(8):1331-40. PubMed ID: 17087427
    [Abstract] [Full Text] [Related]

  • 5. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA, Wells S, Scragg RK, Jackson R.
    N Z Med J; 2008 Sep 05; 121(1281):49-57. PubMed ID: 18797484
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular disease prevention: the new Joint British Societies' guidelines.
    Laker MF, Joint British Societies.
    Ann Clin Biochem; 2006 Sep 05; 43(Pt 5):335-9. PubMed ID: 17022874
    [Abstract] [Full Text] [Related]

  • 7. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.
    Ferrara A, Mangione CM, Kim C, Marrero DG, Curb D, Stevens M, Selby JV, Translating Research Into Action for Diabetes Study Group.
    Diabetes Care; 2008 Jan 05; 31(1):69-74. PubMed ID: 17934157
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [CBO guideline 'High blood pressure' (revision)].
    Grobbee DE, Tuut MK, Hoes AW.
    Ned Tijdschr Geneeskd; 2001 Oct 27; 145(43):2071-6. PubMed ID: 11715592
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, EUROASPIRE Study Group.
    Eur J Cardiovasc Prev Rehabil; 2009 Apr 27; 16(2):121-37. PubMed ID: 19287307
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP, Mikhailidis DP, Moross T, Benson K, Gor M.
    Angiology; 2008 Apr 27; 59(1):36-46. PubMed ID: 18319220
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V.
    Rev Cardiovasc Med; 2007 Apr 27; 8(4):200-13. PubMed ID: 18192943
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.